Y-Intercept (HK)’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-51,591	Closed	-$172K	–	1406
2023 Q4	$172K	Buy	+51,591	New	+$172K	0.02%	1029
2023 Q3	–	Sell	-27,023	Closed	-$115K	–	1113
2023 Q2	$115K	Buy	+27,023	New	+$115K	0.01%	1055